Concurrent chemoradiotherapy plus anlotinib vs. concurrent c…
Emerging
3
Citations29
Refs2023
Year
Search Works
Work Details
- DOI 10.3892/ol.2023.13978
- PMID https://pubmed.ncbi.nlm.nih.gov/37600344
- OpenAlex ID W4386020004
- Type Article
- Language EN
- Published 27 Jul 2023
- Volume 26 (3)
- Pages 392
- Source Oncology Letters
- Publisher Spandidos Publishing
- FWCI 0.67
- Countries 1
- Institutions 4
- Added 10 Oct 2025
- Updated 27 Sep 2026
External Links
MENU
0
Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial
Article 2023 EN Diamond
Despite the use of intensity-modulated radiation therapy (IMRT) and concurrent chemotherapy (CCRT), the treatment of locoregionally advanced nasopharyngeal carcinoma (LA-NPC) is not satisfactory. EGFR and VEGFR are highly expressed in 60-80% of patients with LA-NPC and this is associated with a poor prognosis, which suggests the potential effectiveness of an inhibitor targeting tumor angiogenesis…
3
Citations
29
References
11
Authors
0.67
FWCI
Citations by Year
Last 2 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
11 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Kequan Chen | — | |
| 2 | Guoding Xu | Guangxi Medical University (CN) First People's Hospital of Nan… (CN) | — |
| 3 | Yong Liang | — | |
| 4 | Ping Liang | Guangxi Medical University (CN) First People's Hospital of Nan… (CN) | — |
| 5 | Weiwei Gao | — | |
| 6 | Zhou Li | Guangxi Medical University (CN) First People's Hospital of Nan… (CN) | — |
| 7 | Weichao Liang | — | — |
| 8 | Tao Zheng | — | |
| 9 | Jiaxin Chen | The People's Hospital of Guang… (CN) | |
| 10 | Xiaohua Hu | Guangxi Medical University (CN) First Affiliated Hospital of G… (CN) | |
| 11 | Yao-Can Xu | — | — |
Related Works
10Data: OpenAlex